Announcements Trials

Browse Landscape

Phase

Status

Withdrawn 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uveal Melanoma 1 Neoplasm Metastasis 1

Interventions

trametinib 2 olaparib 1 glembatumumab vedotin 1 durvalumab 1 cediranib 1 Vorinostat 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Ipilimumab 1 CTLA-4 Antigen 1 CR011-vcMMAE 1 Biopsy, Fine-Needle 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Uveal Melanoma × cediranib × Clear all

NCT04184518 2020-06-02

CEDUVEAL-M

Grupo Español Multidisciplinar de Melanoma

Phase 2 Withdrawn

Uveal Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡